Nuvectis Pharma Inc (NASDAQ:NVCT) shares gained 5. 7% in premarket trading on Monday after the company announced a licensing ...
Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with Nuvectis, a U.S. biotechnology company. Under the agreement, Haisco ...
Detailed price information for China Medical System Holdings Ltd (CHSYF) from The Globe and Mail including charting and trades.
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and CSL announced today that the European Medicines Agency's (EMA) ...
Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing ...
By Beatriz Carpallo Porcar, Andrés Ráfales Perucha, Daniel Sanjuán Sánchez, José Lesmes Poveda López and Paula Cordova Alegre ...
Regeneron's cemdisiran won FDA Priority Review and EMA filing acceptance for gMG, backed by phase III data and a potentially ...
(Yicai) June 23 -- Haisco Pharmaceutical Group's shares jumped after the drugmaker granted US' Nuvectis Pharma the exclusive ...
Our immune system works around the clock to protect us from bacteria, viruses, and other harmful germs. It also helps repair damaged tissues after injuries. One of its most important defense tools is ...
Cemdisiran could be the first siRNA approved for the treatment of gMG and only therapy to be offered subcutaneously with four times a year dosing FDA accepted NDA under Priority Review with a target ...
Two new studies jointly published in Nature Communications reveal that certain species of fungi in the gut play a key role in ...
The Clinical Microbiome reveal that certain species of fungi in the gut play a key role in the development of immune ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results